Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. VEEV
VEEV logo

VEEV Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
178.810
Open
175.000
VWAP
175.94
Vol
1.56M
Mkt Cap
28.74B
Low
173.040
Amount
275.27M
EV/EBITDA(TTM)
21.60
Total Shares
163.33M
EV
21.63B
EV/OCF(TTM)
15.28
P/S(TTM)
9.01
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. It offers span cloud software, data and business consulting and is designed to meet the needs of its customers and strategic business functions from research and development (R&D) through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences that gives an artificial intelligence (AI)-driven chat experience.
Show More

Events Timeline

(ET)
2026-03-12
08:50:00
KDK and Others See Significant Increases in Liquidity Borrow Rates
select
2026-03-10 (ET)
2026-03-10
11:50:00
Veeva Systems Acquires Ostro for $100M
select
2026-03-05 (ET)
2026-03-05
09:10:00
U.S. Futures Slip as Investors Weigh Middle East Geopolitical Risks
select

News

Fool
8.5
03-14Fool
Veeva Systems' Market Prospects and Challenges
  • Market Growth Potential: Since its IPO in 2013, Veeva Systems has achieved a compound annual growth rate of 13.6%, and despite facing significant competition, the demand for its cloud solutions in the life sciences sector is expected to continue growing, particularly with the aging global population and increasing consumer spending.
  • Customer Base Advantage: Veeva's clientele includes 15 of the top 20 biopharma companies, and the high switching costs associated with its services enhance its competitive edge and market position, as clients rely heavily on its platform for critical operations.
  • Market Opportunity Assessment: Veeva Systems estimates its current total addressable market at approximately $20 billion, and while revenue growth has slowed, the company still sees ample opportunities for strong revenue and profit growth over the next five years, especially within the life sciences sector.
  • Investment Return Potential: To turn a $70,000 investment into $2 million over 30 years, Veeva would need to achieve an annual compound growth rate of 11.82%, which is slightly lower than its past performance but remains attractive given its market leadership and competitive advantages.
NASDAQ.COM
8.5
03-14NASDAQ.COM
Veeva Systems Faces Competitive Challenges Amid Strong Growth
  • Market Growth Potential: Since its IPO in 2013, Veeva Systems has achieved a compound annual growth rate of 13.6%, and despite facing competitive pressures, the demand in the life sciences sector is expected to grow, benefiting from an aging population and increased consumer spending.
  • Strong Customer Base: Veeva serves 15 of the top 20 biopharma companies, and its clients' reliance on its services for critical activities like clinical trial data management and compliance provides a robust competitive edge.
  • Broad Market Opportunities: With a current total addressable market of approximately $20 billion, Veeva Systems has the potential for strong revenue and profit growth over the next five years, especially as it expands into new markets like cosmetics and consumer packaged goods.
  • Investment Return Potential: To turn a $70,000 investment into $2 million over 30 years, Veeva would need to achieve an 11.82% compound annual growth rate, which, while slightly lower than its historical performance, remains competitive in the current market landscape.
Yahoo Finance
8.5
03-14Yahoo Finance
Veeva Systems: Analyzing Future Growth Potential
  • Market Growth Potential: Since its IPO in 2013, Veeva Systems has achieved a compound annual growth rate of 13.6%, and despite facing competitive pressures, the demand in the life sciences sector is expected to continue growing, particularly with the aging population and increasing consumer spending.
  • Customer Base Advantage: Veeva serves 15 of the top 20 biopharma companies, and the high switching costs for clients relying on its services enhance its market position and competitive edge in the industry.
  • Market Opportunity Assessment: Veeva Systems estimates its current total addressable market at approximately $20 billion, and while revenue growth has slowed, the company still has opportunities for strong revenue and profit growth over the next five years, especially as it expands into new markets.
  • Investment Return Potential: To turn a $70,000 investment into $2 million over 30 years, Veeva would need to achieve an 11.82% compound annual growth rate, which, while slightly lower than its past performance, positions it as a potential long-term investment given its leadership in core markets and competitive advantages.
Yahoo Finance
9.5
03-14Yahoo Finance
Veeva Systems' Strong Q4 Results Attract Analyst Attention
  • Strong Earnings: Veeva Systems Inc. (NYSE:VEEV) reported fourth-quarter results in 2026 that exceeded market expectations, leading Truist to lower its price target from $275 to $262 while maintaining a Buy rating, indicating ongoing commercial momentum.
  • Cautious Outlook: Truist highlighted that Veeva's guidance surpassed consensus estimates, reflecting customer planning cycles rather than expectations for macroeconomic improvements, showcasing the company's relatively cautious approach to guidance.
  • Competitive Advantage: TD Cowen updated its model on the same day, reducing Veeva's price target from $380 to $300 but keeping a Buy rating, emphasizing that the integrated nature of Veeva's platform provides a significant competitive edge and alleviates concerns regarding AI-related risks.
  • Positive Analyst Sentiment: As of March 6, 2026, over 70% of analysts maintain a bullish outlook on Veeva, with a consensus price target of $195.49, implying approximately 40.67% upside potential, despite the stock having fallen over 28% in the past six months.
PRnewswire
7.5
03-11PRnewswire
AOP Health Standardizes on Veeva Vault Platform to Accelerate Global Growth
  • Platform Integration: AOP Health standardizes on the Veeva Vault platform, integrating clinical research, development, quality, and commercialization to enhance global operational efficiency and reduce time to patient access.
  • Collaboration Efficiency: The new platform fosters collaboration among clinical, regulatory, safety, and quality teams, enabling more efficient development of new therapies while improving drug safety and compliance.
  • Clear Market Positioning: AOP Health focuses on providing integrated therapy solutions for rare diseases and critical care, leveraging nearly 30 years of industry experience to address unmet medical needs and strengthen market competitiveness.
  • Deepening Strategic Partnership: The collaboration between Veeva and AOP Health is founded on shared values, aiming to transform the service model for rare diseases and critical care through the Veeva Industry Cloud for Life Sciences, driving industry innovation.
Benzinga
7.5
03-10Benzinga
Veeva Acquires Ostro to Expand AI Engagement Tools
  • Strategic Expansion: Veeva's acquisition of Ostro for approximately $100 million aims to enhance its AI tools, improving interactions between pharmaceutical brands and healthcare professionals, thereby boosting market competitiveness.
  • Technology Integration: Ostro's AI-powered platform allows users to ask health-related questions through a conversational interface, providing verified information instantly, addressing the growing demand for compliant AI communication tools.
  • Data Analysis Capability: The platform not only delivers approved answers and relevant educational materials but also collects engagement data, enabling brands to analyze user behavior and refine digital outreach strategies for improved communication efficiency.
  • Industry Outlook: Veeva CEO Peter Gassner emphasized that AI is reshaping how consumers access health information, and Ostro's technology will ensure patients and doctors have instant access to accurate information, driving future customer engagement models.
Wall Street analysts forecast VEEV stock price to rise
23 Analyst Rating
Wall Street analysts forecast VEEV stock price to rise
16 Buy
6 Hold
1 Sell
Moderate Buy
Current: 0.000
sliders
Low
222.00
Averages
317.10
High
380.00
Current: 0.000
sliders
Low
222.00
Averages
317.10
High
380.00
Citi
Buy
downgrade
$319 -> $219
AI Analysis
2026-03-09
Reason
Citi
Price Target
$319 -> $219
AI Analysis
2026-03-09
downgrade
Buy
Reason
Citi lowered the firm's price target on Veeva to $219 from $319 and keeps a Buy rating on the shares. The firm views the company's Q4 report as strong. Citi cites the compression of software multiples for the target cut.
Citi
Buy
downgrade
$319 -> $291
2026-03-09
Reason
Citi
Price Target
$319 -> $291
2026-03-09
downgrade
Buy
Reason
Citi lowered the firm's price target on Veeva to $291 from $319 and keeps a Buy rating on the shares. The firm views the company's Q4 report as strong. Citi cites the compression of software multiples for the target cut.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for VEEV
Unlock Now

Valuation Metrics

The current forward P/E ratio for Veeva Systems Inc (VEEV.N) is 31.55, compared to its 5-year average forward P/E of 44.19. For a more detailed relative valuation and DCF analysis to assess Veeva Systems Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
44.19
Current PE
31.55
Overvalued PE
61.27
Undervalued PE
27.11

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
31.99
Current EV/EBITDA
23.86
Overvalued EV/EBITDA
43.03
Undervalued EV/EBITDA
20.94

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
14.21
Current PS
11.61
Overvalued PS
18.40
Undervalued PS
10.03

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

which stocks will decrease this week
Intellectia · 42 candidates
Region: USList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceCrossDownMA5, PriceBelowMA20Week Price Change Pct: $-100.00 - $-2.00One Week Rise Prob: 0 - 40One Week Predict Return: -100.0% - -2.0%
Ticker
Name
Market Cap$
top bottom
SYK logo
SYK
Stryker Corp
125.81B
VTR logo
VTR
Ventas Inc
39.03B
VEEV logo
VEEV
Veeva Systems Inc
29.25B
RYTM logo
RYTM
Rhythm Pharmaceuticals Inc
5.64B
DBX logo
DBX
Dropbox Inc
5.58B
CRSP logo
CRSP
CRISPR Therapeutics AG
4.46B
tomorrow’s top pick premarket
Intellectia · 6 candidates
Market Cap: >= 1000.00MRegion: USList Exchange: XNYS, XNAS, XASEOne Day Rise Prob: >= 60One Day Predict Return: >= 1.5%Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
KTB logo
KTB
Kontoor Brands Inc
3.63B
WIX logo
WIX
Wix.Com Ltd
3.87B
URGN logo
URGN
Urogen Pharma Ltd
1.02B
BBY logo
BBY
Best Buy Co Inc
12.98B
VEEV logo
VEEV
Veeva Systems Inc
29.92B
CRWD logo
CRWD
CrowdStrike Holdings Inc
93.78B
AI Picks and Shovels
Intellectia · 26 candidates
Market Cap: >= 5.00BThemes: Cloud Computing, Semiconductor Equipment & Materials, Software as a ServiceGross Margin: >= 30.00Annual Revenue Yoy Growth: >= 5.0%
Ticker
Name
Market Cap$
top bottom
MSFT logo
MSFT
Microsoft Corp
3.30T
PLTR logo
PLTR
Palantir Technologies Inc
394.05B
LRCX logo
LRCX
Lam Research Corp
286.86B
CRM logo
CRM
Salesforce Inc
207.62B
KLAC logo
KLAC
KLA Corp
199.72B
INTU logo
INTU
Intuit Inc
146.07B
Ai stock
Intellectia · 20 candidates
Market Cap: >= 5.00BRegion: USThemes: Semiconductor Equipment & Materials, Technology, Software as a ServiceRevenue 5yr Cagr: >= 8Eps 5yr Cagr: >= 8
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.45T
AAPL logo
AAPL
Apple Inc
3.64T
MSFT logo
MSFT
Microsoft Corp
3.30T
AMZN logo
AMZN
Amazon.com Inc
2.47T
META logo
META
Meta Platforms Inc
1.54T
ASML logo
ASML
ASML Holding NV
526.90B
what about health tech stocks and robots?
Intellectia · 18 candidates
Market Cap: 50.00M - 50.00BWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ROK logo
ROK
Rockwell Automation Inc
47.26B
SYM logo
SYM
Symbotic Inc
36.98B
TER logo
TER
Teradyne Inc
36.32B
VEEV logo
VEEV
Veeva Systems Inc
36.12B
ZBRA logo
ZBRA
Zebra Technologies Corp
12.31B
DOCS logo
DOCS
Doximity Inc
7.50B
what are the AI related stocks?
Intellectia · 8 candidates
Themes: Semiconductor Equipment & Materials, Software as a ServiceEps Ttm: >= 1Revenue 5yr Cagr: >= 15Weekly Average Turnover: >= 1,000,000Pe Ttm: 10 - 50
Ticker
Name
Market Cap$
top bottom
ASML logo
ASML
ASML Holding NV
526.90B
KLAC logo
KLAC
KLA Corp
199.72B
INTU logo
INTU
Intuit Inc
146.07B
VEEV logo
VEEV
Veeva Systems Inc
36.12B
ENTG logo
ENTG
Entegris Inc
18.15B
DOCU logo
DOCU
DocuSign Inc
11.22B
find me the next nvda
Intellectia · 27 candidates
Market Cap: 2.00B - 50.00BRevenue 5yr Cagr: >= 12Eps 5yr Cagr: >= 12Pe Ttm: <= 80
Ticker
Name
Market Cap$
top bottom
VEEV logo
VEEV
Veeva Systems Inc
36.12B
UI logo
UI
Ubiquiti Inc
32.98B
ZM logo
ZM
Zoom Communications Inc
24.04B
GPN logo
GPN
Global Payments Inc
20.54B
SMCI logo
SMCI
Super Micro Computer Inc
19.25B
PTC logo
PTC
PTC Inc
19.18B

Whales Holding VEEV

M
Martin Currie Ltd.
Holding
VEEV
+1.75%
3M Return
T
TimesSquare Capital Management, LLC
Holding
VEEV
+0.53%
3M Return
E
ExodusPoint Capital Management, LP
Holding
VEEV
-2.35%
3M Return
G
General American Investors Company, Inc.
Holding
VEEV
-2.62%
3M Return
H
Hikari Power Ltd.
Holding
VEEV
-2.68%
3M Return
Y
Y-Intercept (Hong Kong) Limited
Holding
VEEV
-2.72%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Veeva Systems Inc (VEEV) stock price today?

The current price of VEEV is 175.96 USD — it has increased 1.95

What is Veeva Systems Inc (VEEV)'s business?

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. It offers span cloud software, data and business consulting and is designed to meet the needs of its customers and strategic business functions from research and development (R&D) through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences that gives an artificial intelligence (AI)-driven chat experience.

What is the price predicton of VEEV Stock?

Wall Street analysts forecast VEEV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VEEV is317.10 USD with a low forecast of 222.00 USD and a high forecast of 380.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Veeva Systems Inc (VEEV)'s revenue for the last quarter?

Veeva Systems Inc revenue for the last quarter amounts to 835.95M USD, increased 15.96

What is Veeva Systems Inc (VEEV)'s earnings per share (EPS) for the last quarter?

Veeva Systems Inc. EPS for the last quarter amounts to 1.49 USD, increased 26.27

How many employees does Veeva Systems Inc (VEEV). have?

Veeva Systems Inc (VEEV) has 7928 emplpoyees as of March 31 2026.

What is Veeva Systems Inc (VEEV) market cap?

Today VEEV has the market capitalization of 28.74B USD.